According to a new study published in the American Journal of Obstetrics and Gynecology, pregnant women are at greater risk of infection with COVID-19.
The study shows that infection rates among pregnant women in Washington state were 70 percent higher than similarly aged adults in the state, Eureclart reported.
It was also found that infection rates among pregnant women of color were two to four times higher than expected.
“The greatest burden of infections in almost all racial / ethnic minority groups, pregnant women were not protected from COVID-19 in the early months of the epidemic,” Researchers wrote.
The study followed 240 pregnant women with COVID-19 in 35 hospitals and clinics by June 2020.
OB-GYN Dr. at the University of Washington School of Medicine. Christina Adams Waldorf said the study provides more evidence that pregnancy should be considered a high-risk health condition for vaccine priority.
“Our data indicates that pregnant people did not let the epidemic survive as we hoped they would, and communities of color put the greatest burden,” Waldorf said.
The study found that pregnant women who were infected had a 3.5-fold higher COVID-associated hospitalization rate than the similarly aged general population in Washington State.
Also, COVID mortality was 13 times higher among pregnant mothers than in individuals of the same age group.
“The death rate was surprisingly high. We were very surprised by this, ”Waldorf said.
He added, “We are seriously concerned that maternal deaths associated with COVID-19 have been suffered at a national level and that the effect on pregnant patients, especially those with underlying conditions, is currently low Is more than ”
Research also found that most pregnant women with COVID-19 had asymptomatic or mild cases and healthy pregnancies.
Of the 240 pregnant women with the infection diagnosed through June, three died of COVID-19, while 24 others were hospitalized.
According to the study, all three were from minority ethnic groups and most of them had other conditions such as obesity and high blood pressure.
The lead author, Dr., including the high infection rates in pregnant women, healthcare, education, service sectors in many businesses and industries considered essential during the COVID-19 epidemic. Said Erica Locan, statement.
On Thursday, Pfizer / BioNTech announced the start of its clinical trial for vaccine evaluation in pregnant women, According to USA Today.
The trial will recruit approximately 4,000 healthy pregnant women over the age of 18 in North America, South America, Europe and Africa.
“It’s time to take the next step and expand our clinical program to pregnant women, such as pregnant women, to potentially protect both them and the generations to come,” according to the outlet Bioentech’s chief Medical Officer Dr. .